Cargando…
Chloroquine and hydroxychloroquine in the context of COVID-19
Chloroquine and closely related structural analogs, employed initially for the treatment of malaria, are now gaining worldwide attention due to the rapidly spreading pandemic caused by severe acute respiratory syndrome-coronavirus-2, named coronavirus disease (COVID) of 2019 (COVID-19). Although muc...
Autores principales: | Shukla, Ashutosh M, Archibald, Lennox K, Wagle Shukla, Aparna, Mehta, Hiren J, Cherabuddi, Kartikeya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192209/ https://www.ncbi.nlm.nih.gov/pubmed/32373183 http://dx.doi.org/10.7573/dic.2020-4-5 |
Ejemplares similares
-
Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues
por: Shukla, Ashutosh M, et al.
Publicado: (2019) -
Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020) -
Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
por: Shetty, Rajesh M, et al.
Publicado: (2021) -
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020) -
Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
por: Stevens, David M., et al.
Publicado: (2020)